Tokushima, Japan

Masahito Komuro

This inventor holds 2 USPTO granted patents. Top assignees: Kuraray Co., Ltd., Taiho Pharmaceutical Company Limited. Active years: 1991-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masahito Komuro. Retrieved from https://idiyas.com/inventor/masahito-komuro

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 11.5

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1991-1994

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Masahito Komuro: Innovator in Anti-Inflammatory Research

Introduction

Masahito Komuro is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of anti-inflammatory research, holding a total of 2 patents. His work focuses on developing innovative compositions that exhibit remarkable therapeutic effects.

Latest Patents

Masahito Komuro's latest patents include formulations such as 11-beta, 17-alpha, 21-trihydroxy-1,4-pregnadiene-3,20-dione and its derivatives. These compositions demonstrate excellent anti-inflammatory action while minimizing side effects. The methods for producing these compounds allow for high selectivity and good yield, making them convenient for practical applications.

Career Highlights

Throughout his career, Komuro has worked with prominent companies such as Kuraray Co., Ltd. and Taiho Pharmaceutical Company Limited. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Masahito Komuro has collaborated with notable colleagues, including Yutaka Mizushima and Keiko Hoshi. Their joint efforts have further advanced the research and development of anti-inflammatory therapies.

Conclusion

Masahito Komuro's contributions to anti-inflammatory research and his innovative patents highlight his role as a significant inventor in the pharmaceutical industry. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…